Nikolas Harbord, MD Email Nikolas Harbord
-
- Position
- ASSISTANT PROFESSOR | Medicine, Nephrology
-
- Specialty
- Nephrology
-
- Language
- English
-
- Hospital Affiliations
- Mount Sinai Beth Israel
- The Mount Sinai Hospital
-
- Phone
- Mount Sinai Union Square 212-420-4070 212-420-4070
Book an Appointment - Nikolas Harbord, MD
Dr. Harbord is a Specialist in Clinical Hypertension (ASH), with an interest in diabetic kidney disease, critical care nephrology and acute kidney injury, chronic kidney disease, edematous states, and electrolyte and acid-base disorders.
Dr. Nikolas Harbord received his medical degree from the UMDNJ-Robert Wood Johnson Medical School (now Rutgers Medical School), and completed both his internal medicine residency and nephrology fellowship at Beth Israel Medical Center (now Mount Sinai Beth Israel). Dr. Harbord is board certified in internal medicine and nephrology. He has served as the program director for the nephrology fellowship since 2012, and as interim division chief since 2014.
Dr. Harbord administers the division of nephrology and the nephrology fellowship program. He directs the weekly diabetic nephropathy clinic at the Friedman Diabetes Center. Dr. Harbordserves MSBI on the pharmacy and therapeutics committee and the Mount Sinai Health System on the Department of Medicine clinical trials review committee. He has published on various topics within nephrology, including nephrotoxicity and mineral bone disease. He was named a New York Rising Star in Nephrology in 2013 & 2014 by Superdoctors.com & NY Times Magazine. He maintains an active dialysis and office practice, and accepts new patients.
Certifications
Nephrology
American Board of Internal Medicine
Clinical Focus
- Acute Renal Failure
- Acute Tubular Necrosis
- Chronic Renal Failure
- Diabetic Kidney Disease
- Dialysis
- Edema/Swelling
- Glomerulonephritis
- Hematuria
- High Blood Pressure
- Hydronephrosis
- Kidney Biopsy
- Kidney Failure
- Kidney Infection
- Kidney Stones
- Kidney Transplant
- Malignant Hypertension
- Nephrotic Syndrome
- Polycystic Kidney Disease
- Renal Artery Stenosis
- Renal Ultrasound
- Renovascular Hypertension
- Urinary Tract Infection
Research Topics
AIDS/HIV, Bone Biology, Diabetes, Kidney
Education
MD, Robert Wood Johnson Medical School
Fellowship, Mount Sinai Beth Israel
MD, Rutgers Medical School
Residency, Mount Sinai Beth Israel
Residency, Internal Medicine
Beth Israel Medical Center
Language
English
2013, 2014
New York Rising Stars- Nephrology
Superdoctors.com & NY Times Magazine
American Registry- Patient's Choice, On Time, Most Compassionate Doctor
I have helped to describe the association between bisphosphonate therapy and adynamic bone disease in CKD patients, by using dynamic bone labeling and bone histology. With my colleagues at MSBI, I have described the inflammation evident in ESRD patients with various types of hemodialysis access. As a co-investigator in an industry funded clinical trial [Multi-Center Study of the Effect of Sevelamer Carbonate on Metabolic/Inflammatory/Reactive Oxygen Species (ROS) in Diabetes with Nephropathy, the AGELESS study] at MSBI and Mount Sinai, I helped recruit study subjects and am involved in the current publication of our findings. I have also guided the comprehensive survey of the impact of Hurricane Sandy on hemodialysis patients in NYC; and will soon publish our findings. As the training program director and division chief (interim) for Nephrology & Hypertension at MSBI I will be responsible for promoting scholarly activity and research among all fellows and faculty.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr.Harbord did not report having any of the following types of financial relationships with industry during 2018 and/or 2019: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website.
Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.